VEGFA and endophthalmitis: Khaqan et al reported a post bevacizumab injection endophthalmitis to be 0.134%.17 Two other studies studying the complications after anti VEGF revealed similar rates of 0.11% and 0.10% respectively.18,19 The rate of endophthalmitis per intravitreal injection of anti VEGF agents at in our hospital was four of 30,258 (0.013%), in an OR setting, in the presence of positive pressure ventilation.